| Ciltacabtagene autoleucel, a B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy in patients with relapsed or refractory multiple myeloma (CARTITUDE-1 … JG Berdeja, D Madduri, SZ Usmani, A Jakubowiak, M Agha, AD Cohen, ... The Lancet 398 (10297), 314-324, 2021 | 1307 | 2021 |
| A computational tool for quantitative analysis of vascular networks E Zudaire, L Gambardella, C Kurcz, S Vermeren PloS one 6 (11), e27385, 2011 | 1028 | 2011 |
| Ciltacabtagene autoleucel, an anti–B-cell maturation antigen chimeric antigen receptor T-cell therapy, for relapsed/refractory multiple myeloma: CARTITUDE-1 2-year follow-up T Martin, SZ Usmani, JG Berdeja, M Agha, AD Cohen, P Hari, D Avigan, ... Journal of Clinical Oncology 41 (6), 1265-1274, 2023 | 467 | 2023 |
| Cilta-cel or standard care in lenalidomide-refractory multiple myeloma J San-Miguel, B Dhakal, K Yong, A Spencer, S Anguille, MV Mateos, ... New England Journal of Medicine 389 (4), 335-347, 2023 | 391 | 2023 |
| Eradication of tumors through simultaneous ablation of CD276/B7-H3-positive tumor cells and tumor vasculature S Seaman, Z Zhu, S Saha, XM Zhang, MY Yang, MB Hilton, K Morris, ... Cancer cell 31 (4), 501-515. e8, 2017 | 360 | 2017 |
| The aryl hydrocarbon receptor repressor is a putative tumor suppressor gene in multiple human cancers E Zudaire, N Cuesta, V Murty, K Woodson, L Adams, N Gonzalez, ... The Journal of clinical investigation 118 (2), 640-650, 2008 | 257 | 2008 |
| COX-2 inhibition potentiates antiangiogenic cancer therapy and prevents metastasis in preclinical models L Xu, J Stevens, MB Hilton, S Seaman, TP Conrads, TD Veenstra, ... Science translational medicine 6 (242), 242ra84-242ra84, 2014 | 227 | 2014 |
| Adrenomedullin and cancer E Zudaire, A Martınez, F Cuttitta Regulatory peptides 112 (1-3), 175-183, 2003 | 218 | 2003 |
| GPR124, an orphan G protein-coupled receptor, is required for CNS-specific vascularization and establishment of the blood–brain barrier M Cullen, MK Elzarrad, S Seaman, E Zudaire, J Stevens, MY Yang, X Li, ... Proceedings of the National Academy of Sciences 108 (14), 5759-5764, 2011 | 213 | 2011 |
| Comprehensive genomic and immunological characterization of Chinese non-small cell lung cancer patients XC Zhang, J Wang, GG Shao, Q Wang, X Qu, B Wang, C Moy, Y Fan, ... Nature communications 10 (1), 1772, 2019 | 196 | 2019 |
| Incidence and management of CAR-T neurotoxicity in patients with multiple myeloma treated with ciltacabtagene autoleucel in CARTITUDE studies AD Cohen, S Parekh, BD Santomasso, J Gállego Pérez-Larraya, ... Blood Cancer Journal 12 (2), 32, 2022 | 166 | 2022 |
| GPR124 functions as a WNT7-specific coactivator of canonical β-catenin signaling E Posokhova, A Shukla, S Seaman, S Volate, MB Hilton, B Wu, H Morris, ... Cell reports 10 (2), 123-130, 2015 | 164 | 2015 |
| The central role of adrenomedullin in host defense E Zudaire, S Portal-Nunez, F Cuttitta Journal of leukocyte biology 80 (2), 237-244, 2006 | 153 | 2006 |
| Expression of complement factor H by lung cancer cells: effects on the activation of the alternative pathway of complement D Ajona, Z Castano, M Garayoa, E Zudaire, MJ Pajares, A Martinez, ... Cancer Research 64 (17), 6310-6318, 2004 | 148 | 2004 |
| Efficacy and safety of cilta-cel in patients with progressive multiple myeloma after exposure to other BCMA-targeting agents AD Cohen, MV Mateos, YC Cohen, P Rodriguez-Otero, B Paiva, ... Blood 141 (3), 219-230, 2023 | 147 | 2023 |
| Abnormal lymphangiogenesis in idiopathic pulmonary fibrosis with insights into cellular and molecular mechanisms S El-Chemaly, D Malide, E Zudaire, Y Ikeda, BA Weinberg, ... Proceedings of the National Academy of Sciences 106 (10), 3958-3963, 2009 | 142 | 2009 |
| Inhibitors of the arachidonic acid pathway and peroxisome proliferator–activated receptor ligands have superadditive effects on lung cancer growth inhibition I Avis, A Martínez, J Tauler, E Zudaire, A Mayburd, R Abu-Ghazaleh, ... Cancer Research 65 (10), 4181-4190, 2005 | 139 | 2005 |
| CARTITUDE-1: phase 1b/2 study of ciltacabtagene autoleucel, a B-cell maturation antigen-directed chimeric antigen receptor T cell therapy, in relapsed/refractory multiple myeloma D Madduri, JG Berdeja, SZ Usmani, A Jakubowiak, M Agha, AD Cohen, ... Blood 136, 22-25, 2020 | 138 | 2020 |
| The combined effect of FGFR inhibition and PD-1 blockade promotes tumor-intrinsic induction of antitumor immunity S Palakurthi, M Kuraguchi, SJ Zacharek, E Zudaire, W Huang, DM Bonal, ... Cancer immunology research 7 (9), 1457-1471, 2019 | 137 | 2019 |
| hnRNP A2/B1 modulates epithelial-mesenchymal transition in lung cancer cell lines J Tauler, E Zudaire, H Liu, J Shih, JL Mulshine Cancer research 70 (18), 7137-7147, 2010 | 133 | 2010 |
